Myriad
bioephemera | May 16, 2009Students and laypeople alike often view biotech patents with baffled disbelief. How is it possible to patent bacteria? Mice? Cell types and DNA sequences? How can someone else "own" gene sequences that all of us have carried inside our bodies since birth?
Honestly, as a biologist, the concept of patenting a gene doesn't really throw me for a loop. Think about it: although we all have genes, we can't read them unless we use a variety of lab techniques, many of them patented. In turn, reading the sequence isn't any use unless we know why we care - that this gene is relevant and can be used to…
rskloot | May 15, 2009
Earlier this week, the American Civil Liberties Union and several other groups filed suit against Myriad Genetics -- the company that holds the patent on the breast cancer gene. They're hoping to get the breast cancer gene patent revoked, but more than that, they're aiming to stop gene patenting all together.
Today, in my new column in Slate's Double X Magazine, I go into the story of the breast cancer gene and the impact the ACLU claims it's had on science and patient care (a hint: it's not good). I also look at the suit itself, the cases that have come before this one, and what they say…